Sensitivity and Specificity of Reflectance Confocal Microscopy and Dermoscopy in Assessing Vitiligo Staging
Journal of Cosmetic Dermatology · 2026-05 · 25 (5)
DOI: 10.1111/jocd.70892 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Cosmetic Dermatology, online erschienen am 05.05.2026. Verfasst von Jiyuan Wu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Wuhan No. 1 Hospital, Wuhan, China. Hauptthemen laut MEDLINE: Vitiligo, Dermoscopy. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hubei Provincial Administration of Traditional Chinese medicine.
Abstract (Originalsprache)
Background
Accurate staging of vitiligo is essential for effective treatment. Current staging primarily relies on clinical manifestations, patients' subjective reports, and physicians' assessments, which may introduce inaccuracies. Reflectance confocal microscopy (RCM) and dermoscopy are auxiliary diagnostic tools in dermatology that support the diagnosis and differentiation of vitiligo; they also assist in staging and evaluating therapeutic efficacy.
Aims
This study aimed to compare the sensitivity and specificity of RCM and dermoscopy in vitiligo staging, providing a more reliable reference for clinical application.
Methods
A retrospective review was conducted of clinical and imaging data from 218 patients with vitiligo who attended the Department of Dermatology at Wuhan No. 1 Hospital between December 2023 and November 2024. Clinical assessment methods—clinical features, Vitiligo Disease Activity score, Wood's lamp examination, and Koebner phenomenon—served as the reference standard for staging. Blinded evaluators independently conducted staging using RCM and dermoscopy. Each modality's sensitivity and specificity were calculated.
Results
Staging results based on RCM and dermoscopy showed strong concordance with clinical evaluation; Kappa values were 0.74 and 0.718, respectively ( p < 0.01). The positive percent agreement and negative percent agreement of RCM staging with clinical assessment were 94.16% and 78.12%, respectively; those metrics for dermoscopy were 87.01% and 89.06%. RCM demonstrated significantly higher sensitivity than dermoscopy ( p = 0.013), whereas dermoscopy showed significantly higher specificity than RCM ( p = 0.039).
Conclusions
RCM and dermoscopy provide significant clinical value in vitiligo staging. RCM shows higher positive percent agreement for detecting progressive disease, whereas dermoscopy shows higher negative percent agreement for confirming stable disease. These tools offer an objective foundation for assessment and support clinical decision‐making.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Wuhan No. 1 Hospital, Wuhan, China.
- Hubei Province and Key Laboratory of Skin Infection and Immunity, Wuhan, China.
- Hubei University of Chinese Medicine, Wuhan, China.
- Department of Dermatology, Xiangyang Hospital of Traditional Chinese Medicine, Xiangyang, China.
ORCID-Profile: Jiyuan Wu, Wenjing Liu, Miaomiao Sun, Liuqing Chen
Förderung
- Hubei Provincial Administration of Traditional Chinese medicine
Zitieren
APA
Wu, J., Liu, W., Sun, M., Jiang, Q., Chen, H., & Chen, L. (2026). Sensitivity and Specificity of Reflectance Confocal Microscopy and Dermoscopy in Assessing Vitiligo Staging. Journal of Cosmetic Dermatology, 25(5). https://doi.org/10.1111/jocd.70892
Vancouver
Wu J, Liu W, Sun M, Jiang Q, Chen H, Chen L. Sensitivity and Specificity of Reflectance Confocal Microscopy and Dermoscopy in Assessing Vitiligo Staging. Journal of Cosmetic Dermatology. 2026;25(5). doi:10.1111/jocd.70892
BibTeX
@article{Wu2026,
author = {Wu, Jiyuan and Liu, Wenjing and Sun, Miaomiao and Jiang, Qian and Chen, Hongying and Chen, Liuqing},
title = {Sensitivity and Specificity of Reflectance Confocal Microscopy and Dermoscopy in Assessing Vitiligo Staging},
journal = {Journal of Cosmetic Dermatology},
year = {2026},
volume = {25},
number = {5},
doi = {10.1111/jocd.70892}
}
EUVIMED